Pembrolizumab vs Spironolactone
Pembrolizumab vs Spironolactone: Overview
This comparison examines the pharmacological differences between Pembrolizumab and Spironolactone.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Spironolactone: Mineralocorticoid receptor antagonist.
Pharmacokinetics
Half-life: Pembrolizumab — 26 days; Spironolactone — 1.4 hours.
Chemical Properties
Molecular Formula: Spironolactone — C24H32O4S.
Molecular Weight: Spironolactone — 416.5740 g/mol.
Type: Pembrolizumab — Antibody; Spironolactone — Small molecule.